IR center

EXTEL 2010 Pan European Awards / Investor Relations
#1 in France (CAC 40)
#1 European Pharmaceutical Company
Sanofi-aventis thanks investors and analysts for the support shown by their votes

Focus

August 30, 2010

Sanofi-aventis non-binding offer to acquire Genzyme

The sanofi-aventis non-binding offer was discussed by the management during a live audio webcast.

• Access the recorded audio webcast and the press release

---

July 29, 2010

Second Quarter 2010 Results

The Second Quarter 2010 results were reviewed by management during a live audio webcast.

• Access the press release, the interview with C. Viehbacher, the presentation and the recorded audio webcast of the conference

---

July 9, 2010

Sanofi-aventis in China – Presentation, Shanghai

Thomas Kelly, Sanofi-aventis’ Vice President, Greater China and Eric NG, Vice-President, Business Innovation & Excellence participated.

• Download the presentation

---

July 1, 2010

Emerging Markets Presentation - Paris

Olivier Charmeil, Vice President, Pharmaceutical Operations, Asia Pacific & Japan, Patrick Aghanian, Country & General Manager, Russia and Heraldo Marchezini, General Manager, Brazil presented on Emerging Markets

• Download the presentation

---

June 30, 2010

Investor conference call moderated by Morningstar

Thomas Kelly, Sanofi-Aventis' Vice President, Greater China presented during the conference call. Download the presentation by Thomas Kelly Access the recorded webcast of the audioconference

---

June 15, 2010

Goldman Sachs Healthcare Conference

Jérôme Contamine, Executive VP, Chief Financial Officer, presented at the conference in Los Angeles. Access the presentation and the recorded webcast of the conference

Upcoming events

Bank of America - Merrill Lynch Healthcare Conference

September 15, 2010
Christopher A. Viehbacher, CEO, will present at the Conference in London.
 

IR Thematic Seminar on Diabetes & Oncology

September 30, 2010
 

• Financial calendar

Latest press releases

September 1, 2010

• Largest Atrial Fibrillation Registry Reveals Poor AF Control and High Rates of Cardiovascular Hospitalization

August 30, 2010

• Teriflunomide Significantly Reduced Annualized Relapse Rate and was well Tolerated in MS patients

August 29, 2010

• Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme

August 29, 2010

• Multaq® First-line Option in New 2010 ESC Guidelines for the Management of Atrial Fibrillation

• All press releases
• RSS Press releases

Business Net Income

• Historical consolidated Net Sales by geographic region
• Historical consolidated Pharma Sales by geographic region and product
• Historical consolidated Vaccines Sales by geographic region

• Adoption of Business Net Income as of Q1 2010
• Business Net Income & Reconciliation of Business Net Income to Adjusted Net Income excluding selected items 2009-2008-2007

Publications

• Half-year financial report 2010
• Annual Review 2009
• Shareholder handbook 2009-2010
• Corporate Social Responsibility 2009
• Annual Report on Form 20-F 2009

• All financial publications
• Accessible version of our publications